Literature DB >> 31712889

[Chromophobe renal cell carcinoma-diagnosis and prognosis].

F Erlmeier1,2.   

Abstract

Chromophobe renal cell carcinoma is one of four malignant kidney tumor subtypes. Due to its morphological variance in clinical pathological routine diagnostics, this subtype can cause certain difficulties. The tumor can be mistaken for more aggressive or benign tumors. In both cases the consequences of misdiagnosis regarding treatment decisions can be serious. Due to the morphological variance of the tumor, it has not yet been possible to develop a generally accepted, prognostically convincing graduation scheme. The aim is to improve the quality of diagnostics and estimation of prognosis for this subtype of tumor in order to optimize patient care.

Entities:  

Keywords:  B7-H1 antigen; Diagnostic errors; Prognosis; Proto-oncogene proteins c‑met; Renal cell carcinoma

Mesh:

Year:  2019        PMID: 31712889     DOI: 10.1007/s00292-019-00696-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

1.  Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.

Authors:  Toni K Choueiri; Bernard Escudier; Thomas Powles; Paul N Mainwaring; Brian I Rini; Frede Donskov; Hans Hammers; Thomas E Hutson; Jae-Lyun Lee; Katriina Peltola; Bruce J Roth; Georg A Bjarnason; Lajos Géczi; Bhumsuk Keam; Pablo Maroto; Daniel Y C Heng; Manuela Schmidinger; Philip W Kantoff; Anne Borgman-Hagey; Colin Hessel; Christian Scheffold; Gisela M Schwab; Nizar M Tannir; Robert J Motzer
Journal:  N Engl J Med       Date:  2015-09-25       Impact factor: 91.245

2.  Interobserver reproducibility of a grading system for chromophobe renal cell carcinoma.

Authors:  A Pérez-Pedrosa; J A Ortiz-Rey; Y Lorenzo-Mahía; B Iglesias-Rodríguez; A Peteiro-Cancelo; J González-Carreró
Journal:  Actas Urol Esp       Date:  2012-10-08       Impact factor: 0.994

3.  c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma.

Authors:  G T Gibney; S A Aziz; R L Camp; P Conrad; B E Schwartz; C R Chen; W K Kelly; H M Kluger
Journal:  Ann Oncol       Date:  2012-09-28       Impact factor: 32.976

4.  Supremacy of modern morphometry in typing renal oncocytoma and malignant look-alikes.

Authors:  Franziska Erlmeier; Annette Feuchtinger; Daniela Borgmann; Martina Rudelius; Michael Autenrieth; Axel Karl Walch; Gregor Weirich
Journal:  Histochem Cell Biol       Date:  2015-05-01       Impact factor: 4.304

5.  c-Met in chromophobe renal cell carcinoma.

Authors:  Franziska Erlmeier; Philipp Ivanyi; Arndt Hartmann; Michael Autenrieth; Max Wiedemann; Wilko Weichert; Sandra Steffens
Journal:  Med Oncol       Date:  2016-12-29       Impact factor: 3.064

6.  PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.

Authors:  R Houston Thompson; Haidong Dong; Christine M Lohse; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

7.  Renal cell carcinoma. II. Histological indicators of prognosis.

Authors:  B Delahunt; J N Nacey
Journal:  Pathology       Date:  1987-07       Impact factor: 5.306

8.  Human chromophobe cell renal carcinoma.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

9.  Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).

Authors:  M Abbas; S Steffens; M Bellut; H Eggers; A Großhennig; J U Becker; G Wegener; A J Schrader; V Grünwald; P Ivanyi
Journal:  Med Oncol       Date:  2016-06-17       Impact factor: 3.064

10.  PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis.

Authors:  Katia R M Leite; Sabrina T Reis; José Pontes Junior; Marcelo Zerati; Daniel de Oliveira Gomes; Luiz H Camara-Lopes; Miguel Srougi
Journal:  Diagn Pathol       Date:  2015-10-15       Impact factor: 2.644

View more
  2 in total

Review 1.  Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.

Authors:  Yakun Fang; Wenjun Ji; Chao Yan
Journal:  Dis Markers       Date:  2022-08-21       Impact factor: 3.464

2.  Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma.

Authors:  Yong-Bo Chen; Liang Gao; Jin-Dong Zhang; Jiang Guo; Ping-Hong You; Liang-You Tang; Ying-Wen Liu
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.